Buz Investors DEA Schedules Insys Therapeutics’ Syndros Insys Therapeutics, Inc. (INSY) ("Insys" or the “Company") today announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II
Market Trends

$INSY DEA Schedules Syndros (dronabinol oral solution) as Schedule II Drug

DEA Schedules Insys Therapeutics’ Syndros (dronabinol oral solution) as Schedule II Drug Buz Investors DEA Schedules Insys Therapeutics’ Syndros  Insys Therapeutics, Inc. (INSY) (“Insys” or the “Company”) today announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II of […]

Minecoin Completes First Stage of ICO Ahead of Schedule
CRYPTOCURRENCY BUZZ

Minecoin Completes First Stage of ICO Ahead of Schedule

Minecoin Completes First Stage of ICO Ahead of Schedule MinexSystems, creator of Minecoin cryptocurrency has announced the completion of ICO’s first stage much before the scheduled date. Minecoin December 16, 2016, Kyiv, Ukraine – MinexSystems has successfully completed the first stage of its ICO, thanks to a commercial bank that acquired rest of the minecoin cryptocurrency. […]